Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen A Harrison

Showing results (71-80 of 318) with videos related to

Pageof 32
Sort By:
Nature Reviews. Gastroenterology & Hepatology|October 24, 2012
Physical activity: an essential component of lifestyle modification in NAFLDBenjamin Rodriguez, Dawn M Torres, Stephen A Harrison
Expert Opinion on Investigational Drugs|December 17, 2022
Icosabutate: targeting metabolic and inflammatory pathways for the treatment of NASHDavid A Fraser, Stephen A Harrison, Detlef Schuppan
Gastroenterology & Hepatology|January 19, 2013
The role of consensus interferon in the current treatment of chronic hepatitis C viral infectionEleanor N Fish, Stephen A Harrison, Tarek Hassanein
Hepatology (Baltimore, Md.)|October 11, 2015
High prevalence of hepatic fibrosis in the setting of coexisting diabetes and hepatic steatosis: A case for selective screening in the general population?Aijaz Ahmed, Ryan B Perumpail, Stephen A Harrison
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 31, 2015
Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and OutcomesAijaz Ahmed, Robert J Wong, Stephen A Harrison
Hepatology (Baltimore, Md.)|April 28, 2022
NAFLD-related hepatocellular carcinoma: The growing challengePir Ahmad Shah, Rashmee Patil, Stephen A Harrison
Journal of Hepatology|March 24, 2018
Corrigendum to "Pharmacotherapy for NASH: Current and emerging" [J Hepatol 68 (2017) 362-375]Monica A Konerman, Jacob C Jones, Stephen A Harrison
Hepatology (Baltimore, Md.)|May 27, 2006
Impact of obesity on treatment of chronic hepatitis CMichael R Charlton, Paul J Pockros, Stephen A Harrison
Hepatology Communications|September 9, 2021
What Does the Future Hold for Patients With Nonalcoholic Steatohepatitis: Diagnostic Strategies and Treatment Options in 2021 and Beyond?Naim Alkhouri, Monica Tincopa, Rohit Loomba, et al.
Hepatology (Baltimore, Md.)|May 1, 2010
Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connectionBrad Q Starley, Christopher J Calcagno, Stephen A Harrison
Pageof 32

Showing results (71-80 of 318) with videos related to

Sort By:
Pageof 32
Nature Reviews. Gastroenterology & Hepatology|October 24, 2012
Physical activity: an essential component of lifestyle modification in NAFLDBenjamin Rodriguez, Dawn M Torres, Stephen A Harrison
Expert Opinion on Investigational Drugs|December 17, 2022
Icosabutate: targeting metabolic and inflammatory pathways for the treatment of NASHDavid A Fraser, Stephen A Harrison, Detlef Schuppan
Gastroenterology & Hepatology|January 19, 2013
The role of consensus interferon in the current treatment of chronic hepatitis C viral infectionEleanor N Fish, Stephen A Harrison, Tarek Hassanein
Hepatology (Baltimore, Md.)|October 11, 2015
High prevalence of hepatic fibrosis in the setting of coexisting diabetes and hepatic steatosis: A case for selective screening in the general population?Aijaz Ahmed, Ryan B Perumpail, Stephen A Harrison
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 31, 2015
Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and OutcomesAijaz Ahmed, Robert J Wong, Stephen A Harrison
Hepatology (Baltimore, Md.)|April 28, 2022
NAFLD-related hepatocellular carcinoma: The growing challengePir Ahmad Shah, Rashmee Patil, Stephen A Harrison
Journal of Hepatology|March 24, 2018
Corrigendum to "Pharmacotherapy for NASH: Current and emerging" [J Hepatol 68 (2017) 362-375]Monica A Konerman, Jacob C Jones, Stephen A Harrison
Hepatology (Baltimore, Md.)|May 27, 2006
Impact of obesity on treatment of chronic hepatitis CMichael R Charlton, Paul J Pockros, Stephen A Harrison
Hepatology Communications|September 9, 2021
What Does the Future Hold for Patients With Nonalcoholic Steatohepatitis: Diagnostic Strategies and Treatment Options in 2021 and Beyond?Naim Alkhouri, Monica Tincopa, Rohit Loomba, et al.
Hepatology (Baltimore, Md.)|May 1, 2010
Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connectionBrad Q Starley, Christopher J Calcagno, Stephen A Harrison
Pageof 32